Review state-of-the-art beta-blocker therapy Beta-adrenoceptor drugs treatment hypertension decades time position first-line therapy hypertension Joint National Committee World Health Organization/International Society Hypertension favorable relationship antihypertensive efficacy drugs rate severity adverse effects particular interest possibility beta blockers coronary artery disease CAD regard secondary prevention CAD significant relevant reductions mortality risk reinfarction prospective double-blind placebo-controlled trials primary preventive effect CAD hand open trials placebo control spite lack clear proof effect logical possibility new findings beta blockers particular interest beta blockade myocardial necrosis patients marked elevations plasma catecholamines due traumatic head injury similar protective effect situations severe stress acute myocardial infarction great clinical value Experimental studies beta blockers antiatherosclerotic effect animals atherogenic diet Again clinical confirmation results great significance 